ciprofloxacin has been researched along with sesquiterpenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Jin, H; Kong, Y; Qi, C; Ruan, Z; Xie, X; Zhang, J; Zou, Y | 1 |
| Arena, ME; Bardón, A; Borkosky, S; Cartagena, E; Garay, JA; Mendoza, L; Verni, MC | 1 |
2 other study(ies) available for ciprofloxacin and sesquiterpenes
| Article | Year |
|---|---|
Biochanin A partially restores the activity of ofloxacin and ciprofloxacin against topoisomerase IV mutation-associated fluoroquinolone-resistant Ureaplasma species.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Genistein; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Phytoalexins; Sesquiterpenes; Ureaplasma | 2017 |
Lipophilic 9,10-Dehydrofukinone Action on Pathogenic and Non-Pathogenic Bacterial Biofilms. Why Is This Main Volatile Metabolite in Senecio?
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Lactobacillus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Senecio; Sesquiterpenes; Staphylococcus aureus; Volatile Organic Compounds | 2020 |